Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1540-2025

stryker Blueprint Mixed Reality Depth Stop Pin, Catalog Number MRUE206; Total Shoulder Arthroplasty Recall

stryker Blueprint Mixed Reality Depth Stop Pin, Catalog Number MRUE206; Total Shoulder Arthroplasty

FDA recall Class II

Ongoing

FDA lists this Class II recall for stryker Blueprint Mixed Reality Depth Stop Pin, Catalog Number MRUE206; Total Shoulder Arthroplasty. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1540-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 5, 2025
FDA report date
Apr 16, 2025
Quantity in commerce
474 units
Distribution
See key details
FDA cause
Device Design

What is being recalled?

stryker Blueprint Mixed Reality Depth Stop Pin, Catalog Number MRUE206; Total Shoulder Arthroplasty

Affected model & UDI checker

Search the exact identifiers published for Z-1540-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
MRUE206stryker Blueprint Mixed Reality Depth Stop Pin, Catalog Number MRUE206; Total Shoulder ArthroplastyCheck source noticeNot specified
Not specifiedstryker Blueprint Mixed Reality Depth Stop Pin, Catalog Number MRUE206; Total Shoulder ArthroplastyCheck source notice03700434022988
FDA code information

All lots manufactured through Oct 2024, Distributed 23-Aug-2023 through 31-Dec-2024, GTIN 03700434022988

View the original FDA recall notice

Why was this product recalled?

Stryker identified an elevated complaint rate related to difficulties using the Blueprint Mixed Reality Guidance Instrumentation system is multifactorial, but in each instance prohibits the system from meeting its intended use. The most commonly reported complaints were related to impaired software functioning, impaired instrumentation functioning, and general difficulties using the product.

What actions did Tornier S.A.S. take?

Stryker issued an URGENT: MEDICAL DEVICE RECALL notice to its consignees on 03/12/2025 via email. The notice explained the issue and requested the following: "1. Immediately check your internal inventory to locate the product listed on the attached business reply form, remove them from their point of use, and isolate/quarantine the unit(s) to prevent accidental use. 2. Return the enclosed business reply form by email to confirm receipt of this notification/document product segregation. 3. Upon receipt of the completed business reply form, Stryker will contact you to arrange for the return of your product(s). 4. Maintain awareness of this communication internally until all required actions have been completed within your facility. 5. If you have further distributed the affected product, please notify the applicable parties at once about this recall. You may copy and distribute this notification letter. a. If possible, inform us if any of the subject devices have been distributed to other organizations, including contact details so that we can inform the recipients appropriately. b. If you are a distributor, note that you are responsible for notifying your affected customers." For questions or concerns, please contact memphis.fieldaction@stryker.com. On 03/27/2025, Stryker issued an updated notice to include and additional product via email.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology